IGC Pharma, Inc. Equity Method Investment, Other than Temporary Impairment
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2015-02-12
- IGC Pharma, Inc. equity method investment, other than temporary impairment for the quarter ending 2014-12-31 was $0.00.
- IGC Pharma, Inc. equity method investment, other than temporary impairment for the quarter ending 2014-09-30 was $0.00.
- IGC Pharma, Inc. equity method investment, other than temporary impairment for the quarter ending 2014-06-30 was $0.00.
- IGC Pharma, Inc. equity method investment, other than temporary impairment for fiscal 2012 was $1.20M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month | Equity Method Investment, Other than Temporary Impairment 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | $0.00 derived: sum of 2 quarters · filed 2015-02-12 | $0.00 10-Q · filed 2015-02-12 | ||
| 2014-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | ||||
| 2012-03-31 | $1.20M 10-K · filed 2013-07-16 | $5.10M 10-Q/A · filed 2012-08-21 | |||
| 2010-03-31 | $1.20M 10-Q · filed 2013-02-13 |